Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Emmaus Life Sciences, Inc.EMMA · Entity 205 | Director · CEO | May 30, 2025 | September 02, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Emmaus Life Sciences, Inc.
Report date May 30, 2025 · Filed September 02, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common stock, $0.001 par valueSEC Table I · non-derivative | IndirectFidelity Roth IRA FBO Willis C. Lee | 229,400 |
Reported balance
After 2025-05-30 transaction · row 1
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 1 · 2025-05-30 · Purchase · Acquired 70,000 · Balance 229,400 F1: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.01 to $0.02, inclusive. The reporting person undertakes to provide to Emmaus Life Sciences, Inc., any security holder of Emmaus Life Sciences, Inc., and the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1), footnote (2), footnote (3), footnote (4), footnote (5) and footnote (6). |
| Common stock, $0.001 par valueSEC Table I · non-derivative | IndirectFidelity Roth IRA FBO Willis C. Lee | 275,400 |
Reported balance
After 2025-08-29 transaction · row 4
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 4 · 2025-08-29 · Purchase · Acquired 170,000 · Balance 275,400 F2: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.0109 to $0.011, inclusive. |
| Common stock, $0.001 par valueSEC Table I · non-derivative | IndirectFidelity Roth IRA FBO Willis C. Lee | 445,400 |
Reported balance
After 2026-08-25 transaction · row 5
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 5 · 2026-08-25 · Purchase · Acquired 46,000 · Balance 445,400 F3: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.034 to $0.039, inclusive. |
| Common stock, $0.001 par valueSEC Table I · non-derivative | IndirectFidelity Roth IRA FBO Willis C. Lee | 495,400 |
Reported balance
After 2026-08-27 transaction · row 6
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 6 · 2026-08-27 · Purchase · Acquired 50,000 · Balance 495,400 F4: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.044 to $0.051, inclusive. |
| Common stock, $0.001 par valueSEC Table I · non-derivative | IndirectFidelity Roth IRA FBO Willis C. Lee | 590,167 |
Reported balance
After 2026-08-28 transaction · row 7
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 7 · 2026-08-28 · Purchase · Acquired 94,767 · Balance 590,167 F5: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.050 to $0.075, inclusive. |
| Common stock, $0.001 par valueSEC Table I · non-derivative | IndirectFidelity Roth IRA FBO Willis C. Lee | 690,167 |
Reported balance
After 2026-08-31 transaction · row 8
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 8 · 2026-08-31 · Purchase · Acquired 100,000 · Balance 690,167 F6: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.046 to $0.05, inclusive. |
| Common stock, $0.001 par valueSEC Table I · non-derivative | Direct | 395,124 |
Reported balance
Holding disclosure · report date 2025-05-30 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 395,124 |
| Common stock, $0.001 par valueSEC Table I · non-derivative | IndirectFidelity Traditional IRA FBO Willis C. Leeee | 241,194 |
Reported balance
Holding disclosure · report date 2025-05-30 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 241,194 |
Filing footnotes · ownership attribution and instrument terms
F1: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.01 to $0.02, inclusive. The reporting person undertakes to provide to Emmaus Life Sciences, Inc., any security holder of Emmaus Life Sciences, Inc., and the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1), footnote (2), footnote (3), footnote (4), footnote (5) and footnote (6).
F2: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.0109 to $0.011, inclusive.
F3: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.034 to $0.039, inclusive.
F4: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.044 to $0.051, inclusive.
F5: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.050 to $0.075, inclusive.
F6: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.046 to $0.05, inclusive.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 31, 2026 Filed Sep 2, 2026 19:05 UTC | Emmaus Life Sciences, Inc. EMMA · Entity 205 | PurchaseCommon stock, $0.001 par value | 100,000 | $0.05 | $5,000.00 |
DisclosureSEC source: 0001193125-26-380023 · ownership.xml · nonDerivative · entry 8 LEE WILLIS C · CIK 0001517775 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Indirect · Fidelity Roth IRA FBO Willis C. Lee Disclosed balance after: 690,167 F6 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.046 to $0.05, inclusive. Read SEC document |
| August 28, 2026 Filed Sep 2, 2026 19:05 UTC | Emmaus Life Sciences, Inc. EMMA · Entity 205 | PurchaseCommon stock, $0.001 par value | 94,767 | $0.06 | $5,686.02 |
DisclosureSEC source: 0001193125-26-380023 · ownership.xml · nonDerivative · entry 7 LEE WILLIS C · CIK 0001517775 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Indirect · Fidelity Roth IRA FBO Willis C. Lee Disclosed balance after: 590,167 F5 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.050 to $0.075, inclusive. Read SEC document |
| August 27, 2026 Filed Sep 2, 2026 19:05 UTC | Emmaus Life Sciences, Inc. EMMA · Entity 205 | PurchaseCommon stock, $0.001 par value | 50,000 | $0.05 | $2,500.00 |
DisclosureSEC source: 0001193125-26-380023 · ownership.xml · nonDerivative · entry 6 LEE WILLIS C · CIK 0001517775 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Indirect · Fidelity Roth IRA FBO Willis C. Lee Disclosed balance after: 495,400 F4 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.044 to $0.051, inclusive. Read SEC document |
| August 25, 2026 Filed Sep 2, 2026 19:05 UTC | Emmaus Life Sciences, Inc. EMMA · Entity 205 | PurchaseCommon stock, $0.001 par value | 46,000 | $0.04 | $1,840.00 |
DisclosureSEC source: 0001193125-26-380023 · ownership.xml · nonDerivative · entry 5 LEE WILLIS C · CIK 0001517775 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Indirect · Fidelity Roth IRA FBO Willis C. Lee Disclosed balance after: 445,400 F3 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.034 to $0.039, inclusive. Read SEC document |
| August 29, 2025 Filed Sep 2, 2026 19:05 UTC | Emmaus Life Sciences, Inc. EMMA · Entity 205 | PurchaseCommon stock, $0.001 par value | 170,000 | $0.01 | $1,700.00 |
DisclosureSEC source: 0001193125-26-380023 · ownership.xml · nonDerivative · entry 4 LEE WILLIS C · CIK 0001517775 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Indirect · Fidelity Roth IRA FBO Willis C. Lee Disclosed balance after: 275,400 F2 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.0109 to $0.011, inclusive. Read SEC document |
| May 30, 2025 Filed Sep 2, 2026 19:05 UTC | Emmaus Life Sciences, Inc. EMMA · Entity 205 | PurchaseCommon stock, $0.001 par value | 70,000 | $0.02 | $1,400.00 |
DisclosureSEC source: 0001193125-26-380023 · ownership.xml · nonDerivative · entry 1 LEE WILLIS C · CIK 0001517775 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Indirect · Fidelity Roth IRA FBO Willis C. Lee Disclosed balance after: 229,400 F1 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.01 to $0.02, inclusive. The reporting person undertakes to provide to Emmaus Life Sciences, Inc., any security holder of Emmaus Life Sciences, Inc., and the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1), footnote (2), footnote (3), footnote (4), footnote (5) and footnote (6). Read SEC document |
| February 29, 2024 Filed Feb 29, 2024 23:11 UTC | Emmaus Life Sciences, Inc. EMMA · Entity 205 | PurchaseCommon stock, $0.001 par value | 77,000 | $0.13 | $10,010.00 |
DisclosureSEC source: 0001209191-24-004124 · doc4.xml · nonDerivative · entry 4 LEE WILLIS C · CIK 0001517775 · Director · Co-President & COO 10b5-1 filing: No plan indicated Ownership: Indirect · By Fidelity Roth IRA FBO Willis C. Lee Disclosed balance after: 159,400 Read SEC document |
| February 28, 2024 Filed Feb 29, 2024 23:11 UTC | Emmaus Life Sciences, Inc. EMMA · Entity 205 | PurchaseCommon stock, $0.001 par value | 15,000 | $0.12 | $1,800.00 |
DisclosureSEC source: 0001209191-24-004124 · doc4.xml · nonDerivative · entry 3 LEE WILLIS C · CIK 0001517775 · Director · Co-President & COO 10b5-1 filing: No plan indicated Ownership: Indirect · By Fidelity Roth IRA FBO Willis C. Lee Disclosed balance after: 82,400 F2 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.12 to $0.13, inclusive. Read SEC document |
| February 27, 2024 Filed Feb 29, 2024 23:11 UTC | Emmaus Life Sciences, Inc. EMMA · Entity 205 | PurchaseCommon stock, $0.001 par value | 10,000 | $0.13 | $1,300.00 |
DisclosureSEC source: 0001209191-24-004124 · doc4.xml · nonDerivative · entry 2 LEE WILLIS C · CIK 0001517775 · Director · Co-President & COO 10b5-1 filing: No plan indicated Ownership: Indirect · By Fidelity Roth IRA FBO Willis C. Lee Disclosed balance after: 67,400 Read SEC document |
| February 26, 2024 Filed Feb 29, 2024 23:11 UTC | Emmaus Life Sciences, Inc. EMMA · Entity 205 | PurchaseCommon stock, $0.001 par value | 13,200 | $0.12 | $1,584.00 |
DisclosureSEC source: 0001209191-24-004124 · doc4.xml · nonDerivative · entry 1 LEE WILLIS C · CIK 0001517775 · Director · Co-President & COO 10b5-1 filing: No plan indicated Ownership: Indirect · By Fidelity Roth IRA FBO Willis C. Lee Disclosed balance after: 57,400 F1 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.12 to $0.13, inclusive. The reporting person undertakes to provide to Emmaus Life Sciences, Inc., any security holder of Emmaus Life Sciences, Inc., and the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) and in footnote (2) to this Form 4. Read SEC document |
| February 01, 2024 Filed Feb 5, 2024 21:32 UTC | Emmaus Life Sciences, Inc. EMMA · Entity 205 | GrantOptions · Derivative | 200,000 | $0.15 Strike: $0.15 | $30,000.00 |
DisclosureSEC source: 0001209191-24-002790 · doc4.xml · derivative · entry 1 LEE WILLIS C · CIK 0001517775 · Director · Co-President & COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 200,000 Underlying: Common Stock · 200,000 shares Expires 2034-01-31 Read SEC document |
| November 30, 2023 Filed Dec 5, 2023 01:33 UTC | Emmaus Life Sciences, Inc. EMMA · Entity 205 | PurchaseCommon stock, $0.001 par value | 7,417 | $0.12 | $890.04 |
DisclosureSEC source: 0001209191-23-057328 · doc4.xml · nonDerivative · entry 6 LEE WILLIS C · CIK 0001517775 · Director · COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 395,124 F3 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.11 to $0.13, inclusive. Read SEC document |
| November 30, 2023 Filed Jan 3, 2024 21:59 UTC Amendment | Emmaus Life Sciences, Inc. EMMA · Entity 205 | PurchaseCommon stock, $0.001 par value | 59,400 | $0.12 | $7,128.00 |
DisclosureSEC source: 0001209191-24-000442 · doc4a.xml · nonDerivative · entry 6 LEE WILLIS C · CIK 0001517775 · Director · COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 395,124 F2 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.11 to $0.13, inclusive. Read SEC document |
| November 29, 2023 Filed Dec 5, 2023 01:33 UTC | Emmaus Life Sciences, Inc. EMMA · Entity 205 | PurchaseCommon stock, $0.001 par value | 4,325 | $0.12 | $519.00 |
DisclosureSEC source: 0001209191-23-057328 · doc4.xml · nonDerivative · entry 5 LEE WILLIS C · CIK 0001517775 · Director · COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 335,724 F2 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.11 to $0.13, inclusive. Read SEC document |
| November 29, 2023 Filed Jan 3, 2024 21:59 UTC Amendment | Emmaus Life Sciences, Inc. EMMA · Entity 205 | PurchaseCommon stock, $0.001 par value | 36,000 | $0.12 | $4,320.00 |
DisclosureSEC source: 0001209191-24-000442 · doc4a.xml · nonDerivative · entry 5 LEE WILLIS C · CIK 0001517775 · Director · COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 335,724 F2 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.11 to $0.13, inclusive. Read SEC document |
| November 28, 2023 Filed Dec 5, 2023 01:33 UTC | Emmaus Life Sciences, Inc. EMMA · Entity 205 | PurchaseCommon stock, $0.001 par value | 1,470 | $0.12 | $176.40 |
DisclosureSEC source: 0001209191-23-057328 · doc4.xml · nonDerivative · entry 4 LEE WILLIS C · CIK 0001517775 · Director · COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 299,724 F1 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.12 to $0.13, inclusive. The reporting person undertakes to provide to Emmaus Life Sciences, Inc., any security holder of Emmaus Life Sciences, Inc., and the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) and in footnotes (2) and (3) to this Form 4. Read SEC document |
| November 28, 2023 Filed Jan 3, 2024 21:59 UTC Amendment | Emmaus Life Sciences, Inc. EMMA · Entity 205 | PurchaseCommon stock, $0.001 par value | 12,000 | $0.12 | $1,440.00 |
DisclosureSEC source: 0001209191-24-000442 · doc4a.xml · nonDerivative · entry 4 LEE WILLIS C · CIK 0001517775 · Director · COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 299,724 F1 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.12 to $0.13, inclusive. The reporting person undertakes to provide to Emmaus Life Sciences, Inc., any security holder of Emmaus Life Sciences, Inc., and the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) and in footnotes (2) and (3) to this Form 4. Read SEC document |
| November 14, 2023 Filed Dec 5, 2023 01:33 UTC | Emmaus Life Sciences, Inc. EMMA · Entity 205 | PurchaseCommon stock, $0.001 par value | 132 | $0.12 | $15.84 |
DisclosureSEC source: 0001209191-23-057328 · doc4.xml · nonDerivative · entry 3 LEE WILLIS C · CIK 0001517775 · Director · COO 10b5-1 filing: No plan indicated Ownership: Indirect · By Fidelity Roth IRA FBO Willis C. Lee Disclosed balance after: 44,200 Read SEC document |
| November 14, 2023 Filed Jan 3, 2024 21:59 UTC Amendment | Emmaus Life Sciences, Inc. EMMA · Entity 205 | PurchaseCommon stock, $0.001 par value | 1,100 | $0.12 | $132.00 |
DisclosureSEC source: 0001209191-24-000442 · doc4a.xml · nonDerivative · entry 3 LEE WILLIS C · CIK 0001517775 · Director · COO 10b5-1 filing: No plan indicated Ownership: Indirect · By Fidelity Roth IRA FBO Willis C. Lee Disclosed balance after: 44,200 Read SEC document |
| August 31, 2023 Filed Dec 5, 2023 01:33 UTC | Emmaus Life Sciences, Inc. EMMA · Entity 205 | PurchaseCommon stock, $0.001 par value | 900 | $0.15 | $135.00 |
DisclosureSEC source: 0001209191-23-057328 · doc4.xml · nonDerivative · entry 2 LEE WILLIS C · CIK 0001517775 · Director · COO 10b5-1 filing: No plan indicated Ownership: Indirect · By Fidelity Roth IRA FBO Willis C. Lee Disclosed balance after: 43,100 Read SEC document |
| August 31, 2023 Filed Jan 3, 2024 21:59 UTC Amendment | Emmaus Life Sciences, Inc. EMMA · Entity 205 | PurchaseCommon stock, $0.001 par value | 6,000 | $0.15 | $900.00 |
DisclosureSEC source: 0001209191-24-000442 · doc4a.xml · nonDerivative · entry 2 LEE WILLIS C · CIK 0001517775 · Director · COO 10b5-1 filing: No plan indicated Ownership: Indirect · By Fidelity Roth IRA FBO Willis C. Lee Disclosed balance after: 43,100 Read SEC document |
| August 25, 2023 Filed Dec 5, 2023 01:33 UTC | Emmaus Life Sciences, Inc. EMMA · Entity 205 | PurchaseCommon stock, $0.001 par value | 1,365 | $0.21 | $286.65 |
DisclosureSEC source: 0001209191-23-057328 · doc4.xml · nonDerivative · entry 1 LEE WILLIS C · CIK 0001517775 · Director · COO 10b5-1 filing: No plan indicated Ownership: Indirect · By Fidelity Roth IRA FBO Willis C. Lee Disclosed balance after: 37,100 Read SEC document |
| August 25, 2023 Filed Jan 3, 2024 21:59 UTC Amendment | Emmaus Life Sciences, Inc. EMMA · Entity 205 | PurchaseCommon stock, $0.001 par value | 6,500 | $0.21 | $1,365.00 |
DisclosureSEC source: 0001209191-24-000442 · doc4a.xml · nonDerivative · entry 1 LEE WILLIS C · CIK 0001517775 · Director · COO 10b5-1 filing: No plan indicated Ownership: Indirect · By Fidelity Roth IRA FBO Willis C. Lee Disclosed balance after: 37,100 Read SEC document |
| May 31, 2023 Filed Jun 2, 2023 17:23 UTC | Emmaus Life Sciences, Inc. EMMA · Entity 205 | PurchaseCommon stock, $0.001 par value | 28,700 | $0.29 | $8,323.00 |
DisclosureSEC source: 0001209191-23-033573 · doc4.xml · nonDerivative · entry 2 LEE WILLIS C · CIK 0001517775 · Director · COO 10b5-1 filing: No plan indicated Ownership: Indirect · By Fidelity Roth IRA FBO Willis C. Lee Disclosed balance after: 30,600 F1 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.28 to $0.32, inclusive. The reporting person undertakes to provide to Emmaus Life Sciences, Inc., any security holder of Emmaus Life Sciences, Inc., and the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1). Read SEC document |
| January 12, 2023 Filed Jan 17, 2023 19:27 UTC | Emmaus Life Sciences, Inc. EMMA · Entity 205 | GrantOptions · Derivative | 750,000 | $4.50 Strike: $4.50 | $3,375,000.00 |
DisclosureSEC source: 0001209191-23-003460 · doc4.xml · derivative · entry 1 LEE WILLIS C · CIK 0001517775 · Director · COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 750,000 Underlying: Common Stock · 750,000 shares Expires 2033-01-11 F1 · derivative.exercise_date: The options vest as to one-third of the option shares on the 12-month anniversary of the grant date and as to the remaining two-thirds of the option shares in 24 equal monthly installments as of the end of each month after such anniversary. Read SEC document |
| January 12, 2023 Filed Jan 19, 2023 22:54 UTC Amendment | Emmaus Life Sciences, Inc. EMMA · Entity 205 | GrantOptions · Derivative | 500,000 | $4.50 Strike: $4.50 | $2,250,000.00 |
DisclosureSEC source: 0001209191-23-004070 · doc4a.xml · derivative · entry 1 LEE WILLIS C · CIK 0001517775 · Director · COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 500,000 Underlying: Common Stock · 500,000 shares Expires 2033-01-11 F1 · derivative.exercise_date: The options vest as to one-third of the option shares on the 12-month anniversary of the grant date and as to the remaining two-thirds of the option shares in 24 equal monthly installments as of the end of each month after such anniversary. Read SEC document |
| September 20, 2022 Filed Jun 2, 2023 17:23 UTC | Emmaus Life Sciences, Inc. EMMA · Entity 205 | PurchaseCommon stock, $0.001 par value | 750 | $0.28 | $210.00 |
DisclosureSEC source: 0001209191-23-033573 · doc4.xml · nonDerivative · entry 1 LEE WILLIS C · CIK 0001517775 · Director · COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 287,724 Read SEC document |
| July 19, 2022 Filed Jul 25, 2022 16:49 UTC | Emmaus Life Sciences, Inc. EMMA · Entity 205 | PurchaseCommon stock, $0.001 par value | 3,200 | $0.39 | $1,248.00 |
DisclosureSEC source: 0001209191-22-043081 · doc4.xml · nonDerivative · entry 1 LEE WILLIS C · CIK 0001517775 · Director · COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 286,974 Read SEC document |
| May 31, 2022 Filed Jun 3, 2022 15:52 UTC | Emmaus Life Sciences, Inc. EMMA · Entity 205 | PurchaseCommon stock, $0.001 par value | 2,500 | $0.40 | $1,000.00 |
DisclosureSEC source: 0001209191-22-033847 · doc4.xml · nonDerivative · entry 2 LEE WILLIS C · CIK 0001517775 · Director · Director & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 283,774 Read SEC document |
| May 27, 2022 Filed Jun 3, 2022 15:52 UTC | Emmaus Life Sciences, Inc. EMMA · Entity 205 | PurchaseCommon stock, $0.001 par value | 2,500 | $0.37 | $925.00 |
DisclosureSEC source: 0001209191-22-033847 · doc4.xml · nonDerivative · entry 1 LEE WILLIS C · CIK 0001517775 · Director · Director & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 281,274 Read SEC document |
| April 11, 2022 Filed Apr 12, 2022 19:59 UTC | Emmaus Life Sciences, Inc. EMMA · Entity 205 | PurchaseCommon stock, $0.001 par value | 8,900 | $0.88 | $7,832.00 |
DisclosureSEC source: 0001209191-22-024129 · doc4.xml · nonDerivative · entry 4 LEE WILLIS C · CIK 0001517775 · Director · Director & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 278,774 F2 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.85 to $0.89, inclusive. Read SEC document |
| April 08, 2022 Filed Apr 12, 2022 19:59 UTC | Emmaus Life Sciences, Inc. EMMA · Entity 205 | PurchaseCommon stock, $0.001 par value | 1,600 | $0.76 | $1,216.00 |
DisclosureSEC source: 0001209191-22-024129 · doc4.xml · nonDerivative · entry 3 LEE WILLIS C · CIK 0001517775 · Director · Director & COO 10b5-1 filing: Not disclosed Ownership: Indirect · By Fidelity Traditional IRA FBO Willis C. Lee Disclosed balance after: 241,194 F1 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.75 to $0.78, inclusive. The reporting person undertakes to provide to Emmaus Life Sciences, Inc., any security holder of Emmaus Life Sciences, Inc., and the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) and in footnote (2) to this Form 4. Read SEC document |
| April 06, 2022 Filed Apr 12, 2022 19:59 UTC | Emmaus Life Sciences, Inc. EMMA · Entity 205 | PurchaseCommon stock, $0.001 par value | 1,400 | $0.95 | $1,330.00 |
DisclosureSEC source: 0001209191-22-024129 · doc4.xml · nonDerivative · entry 2 LEE WILLIS C · CIK 0001517775 · Director · Director & COO 10b5-1 filing: Not disclosed Ownership: Indirect · By Fidelity Traditional IRA FBO Willis C. Lee Disclosed balance after: 239,594 Read SEC document |
| April 04, 2022 Filed Apr 12, 2022 19:59 UTC | Emmaus Life Sciences, Inc. EMMA · Entity 205 | PurchaseCommon stock, $0.001 par value | 3,200 | $0.98 | $3,136.00 |
DisclosureSEC source: 0001209191-22-024129 · doc4.xml · nonDerivative · entry 1 LEE WILLIS C · CIK 0001517775 · Director · Director & COO 10b5-1 filing: Not disclosed Ownership: Indirect · By Fidelity Traditional IRA FBO Willis C. Lee Disclosed balance after: 238,194 Read SEC document |
| February 28, 2022 Filed Feb 28, 2022 22:34 UTC | Emmaus Life Sciences, Inc. EMMA · Entity 205 | PurchaseCommon stock, $0.001 par value | 900 | $1.65 | $1,485.00 |
DisclosureSEC source: 0001209191-22-013725 · doc4.xml · nonDerivative · entry 5 LEE WILLIS C · CIK 0001517775 · Director · Vice Chairman & COO 10b5-1 filing: Not disclosed Ownership: Indirect · By Fidelity Roth IRA FBO Willis C. Lee Disclosed balance after: 1,900 Read SEC document |
| February 28, 2022 Filed Feb 28, 2022 22:34 UTC | Emmaus Life Sciences, Inc. EMMA · Entity 205 | PurchaseCommon stock, $0.001 par value | 6,600 | $1.50 | $9,900.00 |
DisclosureSEC source: 0001209191-22-013725 · doc4.xml · nonDerivative · entry 4 LEE WILLIS C · CIK 0001517775 · Director · Vice Chairman & COO 10b5-1 filing: Not disclosed Ownership: Indirect · By Fidelity Traditional IRA FBO Willis C. Lee Disclosed balance after: 234,994 F3 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.42 to $1.60, inclusive. Read SEC document |
| February 28, 2022 Filed Feb 28, 2022 22:34 UTC | Emmaus Life Sciences, Inc. EMMA · Entity 205 | PurchaseCommon stock, $0.001 par value | 7,200 | $1.51 | $10,872.00 |
DisclosureSEC source: 0001209191-22-013725 · doc4.xml · nonDerivative · entry 3 LEE WILLIS C · CIK 0001517775 · Director · Vice Chairman & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 269,874 F2 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.41 to $1.54, inclusive. Read SEC document |
| February 24, 2022 Filed Feb 28, 2022 22:34 UTC | Emmaus Life Sciences, Inc. EMMA · Entity 205 | PurchaseCommon stock, $0.001 par value | 5,900 | $1.44 | $8,496.00 |
DisclosureSEC source: 0001209191-22-013725 · doc4.xml · nonDerivative · entry 2 LEE WILLIS C · CIK 0001517775 · Director · Vice Chairman & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 262,674 F1 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.42 to $1.44, inclusive. The reporting person undertakes to provide to Emmaus Life Sciences, Inc., any security holder of Emmaus Life Sciences, Inc., and the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) and in footnotes (2) and (3) to this Form 4. Read SEC document |
| February 22, 2022 Filed Feb 28, 2022 22:34 UTC | Emmaus Life Sciences, Inc. EMMA · Entity 205 | PurchaseCommon stock, $0.001 par value | 500 | $1.42 | $710.00 |
DisclosureSEC source: 0001209191-22-013725 · doc4.xml · nonDerivative · entry 1 LEE WILLIS C · CIK 0001517775 · Director · Vice Chairman & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 256,774 Read SEC document |
| December 17, 2021 Filed Jan 5, 2022 16:52 UTC | Emmaus Life Sciences, Inc. EMMA · Entity 205 | PurchaseCommon stock, $0.001 par value | 500 | $1.50 | $750.00 |
DisclosureSEC source: 0001209191-22-001426 · doc4.xml · nonDerivative · entry 4 LEE WILLIS C · CIK 0001517775 · Director · Vice Chairman & COO 10b5-1 filing: Not disclosed Ownership: Indirect · By Fidelity Roth IRA FBO Willis C. Lee Disclosed balance after: 1,000 Read SEC document |
| December 13, 2021 Filed Jan 5, 2022 16:52 UTC | Emmaus Life Sciences, Inc. EMMA · Entity 205 | PurchaseCommon stock, $0.001 par value | 500 | $1.52 | $760.00 |
DisclosureSEC source: 0001209191-22-001426 · doc4.xml · nonDerivative · entry 3 LEE WILLIS C · CIK 0001517775 · Director · Vice Chairman & COO 10b5-1 filing: Not disclosed Ownership: Indirect · By Fidelity Roth IRA FBO Willis C. Lee Disclosed balance after: 500 Read SEC document |
| December 10, 2021 Filed Jan 5, 2022 16:52 UTC | Emmaus Life Sciences, Inc. EMMA · Entity 205 | PurchaseCommon stock, $0.001 par value | 200 | $1.74 | $348.00 |
DisclosureSEC source: 0001209191-22-001426 · doc4.xml · nonDerivative · entry 2 LEE WILLIS C · CIK 0001517775 · Director · Vice Chairman & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 256,274 Read SEC document |
| December 03, 2021 Filed Jan 5, 2022 16:52 UTC | Emmaus Life Sciences, Inc. EMMA · Entity 205 | PurchaseCommon stock, $0.001 par value | 500 | $1.54 | $770.00 |
DisclosureSEC source: 0001209191-22-001426 · doc4.xml · nonDerivative · entry 1 LEE WILLIS C · CIK 0001517775 · Director · Vice Chairman & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 256,074 F1 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.53 to $1.55, inclusive. The reporting person undertakes to provide to Emmaus Life Sciences, Inc., any security holder of Emmaus Life Sciences, Inc., and the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1). Read SEC document |
| November 30, 2021 Filed Nov 30, 2021 22:45 UTC | Emmaus Life Sciences, Inc. EMMA · Entity 205 | PurchaseCommon stock, $0.001 par value | 15,500 | $1.50 | $23,250.00 |
DisclosureSEC source: 0001209191-21-067167 · doc4.xml · nonDerivative · entry 3 LEE WILLIS C · CIK 0001517775 · Director · Vice Chairman & COO 10b5-1 filing: Not disclosed Ownership: Indirect · By Fidelity Traditional IRA FBO Willis C. Lee Disclosed balance after: 228,394 F3 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.39 to $1.53, inclusive. Read SEC document |
| November 29, 2021 Filed Nov 30, 2021 22:45 UTC | Emmaus Life Sciences, Inc. EMMA · Entity 205 | PurchaseCommon stock, $0.001 par value | 15,705 | $1.47 | $23,086.35 |
DisclosureSEC source: 0001209191-21-067167 · doc4.xml · nonDerivative · entry 2 LEE WILLIS C · CIK 0001517775 · Director · Vice Chairman & COO 10b5-1 filing: Not disclosed Ownership: Indirect · By Fidelity Traditional IRA FBO Willis C. Lee Disclosed balance after: 212,894 F2 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.38 to $1.50, inclusive. Read SEC document |
| November 26, 2021 Filed Nov 30, 2021 22:45 UTC | Emmaus Life Sciences, Inc. EMMA · Entity 205 | PurchaseCommon stock, $0.001 par value | 24,328 | $1.45 | $35,275.60 |
DisclosureSEC source: 0001209191-21-067167 · doc4.xml · nonDerivative · entry 1 LEE WILLIS C · CIK 0001517775 · Director · Vice Chairman & COO 10b5-1 filing: Not disclosed Ownership: Indirect · By Fidelity Traditional IRA FBO Willis C. Lee Disclosed balance after: 197,189 F1 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.28 to $1.50, inclusive. The reporting person undertakes to provide to Emmaus Life Sciences, Inc., any security holder of Emmaus Life Sciences, Inc., and the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) and in footnotes (2) and (3) to this Form 4. Read SEC document |
| November 24, 2021 Filed Nov 26, 2021 21:05 UTC | Emmaus Life Sciences, Inc. EMMA · Entity 205 | PurchaseCommon stock, $0.001 par value | 34,500 | $1.34 | $46,230.00 |
DisclosureSEC source: 0001209191-21-066920 · doc4.xml · nonDerivative · entry 2 LEE WILLIS C · CIK 0001517775 · Director · Vice Chairman & COO 10b5-1 filing: Not disclosed Ownership: Indirect · By Fidelity Traditional IRA FBO Willis C. Lee Disclosed balance after: 172,861 F2 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.29 to $1.35, inclusive. Read SEC document |
| November 23, 2021 Filed Nov 26, 2021 21:05 UTC | Emmaus Life Sciences, Inc. EMMA · Entity 205 | PurchaseCommon stock, $0.001 par value | 3,500 | $1.32 | $4,620.00 |
DisclosureSEC source: 0001209191-21-066920 · doc4.xml · nonDerivative · entry 1 LEE WILLIS C · CIK 0001517775 · Director · Vice Chairman & COO 10b5-1 filing: Not disclosed Ownership: Indirect · By Fidelity Traditional IRA FBO Willis C. Lee Disclosed balance after: 138,361 F1 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.26 to $1.35, inclusive. The reporting person undertakes to provide to Emmaus Life Sciences, Inc., any security holder of Emmaus Life Sciences, Inc., and the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) and in footnote (2) to this Form 4. Read SEC document |
| November 22, 2021 Filed Nov 23, 2021 21:27 UTC | Emmaus Life Sciences, Inc. EMMA · Entity 205 | PurchaseCommon stock, $0.001 par value | 8,900 | $1.44 | $12,816.00 |
DisclosureSEC source: 0001209191-21-066428 · doc4.xml · nonDerivative · entry 5 LEE WILLIS C · CIK 0001517775 · Director · Vice Chairman & COO 10b5-1 filing: Not disclosed Ownership: Indirect · By Fidelity Traditional IRA FBO Willis C. Lee Disclosed balance after: 134,861 F5 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.39 to $1.49, inclusive Read SEC document |
| November 19, 2021 Filed Nov 23, 2021 21:27 UTC | Emmaus Life Sciences, Inc. EMMA · Entity 205 | PurchaseCommon stock, $0.001 par value | 5,000 | $1.37 | $6,850.00 |
DisclosureSEC source: 0001209191-21-066428 · doc4.xml · nonDerivative · entry 4 LEE WILLIS C · CIK 0001517775 · Director · Vice Chairman & COO 10b5-1 filing: Not disclosed Ownership: Indirect · By Fidelity Traditional IRA FBO Willis C. Lee Disclosed balance after: 125,961 F4 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.30 to $1.40, inclusive. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.